Organization Overview
Alternative names
aldesleukin (Proleukin) (1 trial)
autologous anti-h3.3k27m tcr-expressing t-cells (1 trial)
autologous tumor infiltrating lymphocytes (1 trial)
Carcinoma (Phase 2)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Central Nervous System Neoplasms (Phase 1)
Glioma (Phase 1)
Head and Neck Neoplasms (Phase 2)
Immune System Diseases (Phase 1)
Immunoproliferative Disorders (Phase 1)
Lymphatic Diseases (Phase 1)
Lymphoma (Phase 1)
Lymphoma, B-Cell (Phase 1)
Neoplasms (Phase 2)
Nervous System Neoplasms (Phase 1)
Neuroendocrine Tumors (Phase 2)
Pancreatic Neoplasms (Phase 2)
Peripheral Nervous System Diseases (Phase 2)
Prostatic Neoplasms (Phase 1)
Sarcoma (Phase 1)
Squamous Cell Carcinoma of Head and Neck (Phase 2)